Home > Press > Using chitosan core-shell nanoparticle for breast cancer treatment
Abstract:
Researchers at National Nanotechnology Center (NANOTEC) and King Mongkut's University of Technology Thonburi (KMUTT) have successfully developed a target drug delivery system using folate-conjugated pluronic F127/chitosan core-shell nanoparticles to deliver doxorubicin (DOX) to target cancer cells focusing on breast cancer.
"DOX is one of the most commonly used chemotherapeutic agents for cancer treatment including breast cancer. However, DOX is also considered a poor soluble drug that is toxic to healthy tissues" said Dr. Nuttaporn Pimpha, a NANOTEC researcher at Hybrid Nanostructure and Nanocomposite. "By using core-shell nanoparticles from folate-conjugated pluronic F127/chitosan we were able to develop a delivery vector that has greater targeting ability, chemical stability and lower cytotoxicity".
As in many developing countries, cancer in Thailand is becoming a significant health problem. Cervix and breast cancer is the leading cause of death in Thai women. The only commercial DOX - encapsulated liposome available is Doxil. However, Doxil has a short half-life in microcirculation and is unstable in the blood stream. Hence there is a need to find a more controlled and stable DOX carrier system.
The researchers reported their work in a paper published by the Journal of Nanomaterials.
####
For more information, please click here
Contacts:
Ramjitti Indaraprasirt
Manager
Public Relations Section
NANOTEC
02-564-7100 ext: 6617
Copyright ? NANOTEC
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
NSS Congratulates SpaceX Team -- Calls on Congress to Fully Fund Commercial Crew & Space Technology June 1st, 2012
Rational Design of Nanomaterials Takes a Step Forward June 1st, 2012
Nanotechnology breakthrough could dramatically improve medical tests June 1st, 2012
Mirrorcle Technologies? MEMS mirrors scan full hemisphere May 31st, 2012
Nanomedicine
Nanotechnology breakthrough could dramatically improve medical tests June 1st, 2012
Nanostart-holding MagForce signs distribution agreement with Turkish medical product distribution company Tek Grup May 31st, 2012
Harris & Harris Group Notes OpGen and Life Technologies Collaboration Agreement May 30th, 2012
8th NanoBio-Europe conference, Varese, 18 - 20 June 2012 May 30th, 2012
Announcements
Nanotechnology breakthrough could dramatically improve medical tests June 1st, 2012
Nanostart-holding MagForce signs distribution agreement with Turkish medical product distribution company Tek Grup May 31st, 2012
Asylum Research Introduces the AFM Industry?s First Five-Year Instrument Warranty May 31st, 2012
Mirrorcle Technologies? MEMS mirrors scan full hemisphere May 31st, 2012
meteor showers 2012 ufc 145 jones vs evans bobby valentine bobby valentine marian hossa philip humber
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.